Navigation Links
ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants

re-based drug design, and is developing compounds for the treatment of hepatitis C infection, hepatitis B infection and cancer.

About LG Life Sciences

LG Life Sciences, Ltd. ("LGLS") is the leading pharmaceutical company based in South Korea, committed to promoting health and well-being of patients. Its key therapeutic areas include metabolic and cardiovascular diseases as well as infectious and liver diseases. LGLS seeks to continue developing global brand products, such as Factive(R) (gemifloxacin), and expanding its market presence in the world with focus in Asia. Additional information is available on its corporate website, www.lgls.com.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to the believed potential spectrum of activity of ANA380/LB80380 against a defined panel of genetically defined drug-resistant HBV variants, the possibility that ANA380/LB80380 will have clinical utility not only in drug-naïve patients but also in patients who have become resistant to the most commonly used HBV therapeutic agents, the possibility that ANA380/LB80380 used in combination with existing drugs could help prevent the emergence of resistance, future development activities for ANA380/LB80380, and statements regarding the projected future market expansion for HBV therapies. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. In particular, the results of in vitro studies and initial clinical trials may not be predictive of future results, and Anadys cannot provide any assurances that any of its product candidates will not hav
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
3. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
6. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
7. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
10. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
11. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
Post Your Comments:
(Date:9/3/2015)... MUMBAI, India , Sept. 3, 2015  Cipla, ... to meet the everyday needs of all patients, today ... into definitive agreements to acquire two US-based companies, InvaGen ... subject to certain closing conditions, is valued at $550 ... combined revenue from these transactions is over $200 million ...
(Date:9/3/2015)... 2015 Report Details Ovarian ... Industry Changes and Emerging Opportunities What,s the future ... new study forecasts those pharmaceutical revenues. There you ... You also explore trends, results, treatments, R&D, and ... revenue predictions to 2025 at overall world market, ...
(Date:9/3/2015)... LONDON , Sept. 3, 2015 ... ophthalmic devices market? Which areas are going to grow ... you potential revenues to 2025, assessing data, trends, opportunities ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... , BLOOMINGTON, Minn., Oct. 12 The Child Neurology Foundation ... centered on infantile spasms (IS). The website, ... CNF as one of the key components of Infantile Spasms ... announced that the first annual IS Awareness Week will place ...
... Merial, the Animal Health division of the sanofi-aventis ... that Merial Animal Health Co. (China) held a ground-breaking ceremony ... Nanchang Hi-tech Development Zone, China. Merial Animal Health Co. ... production facility in China has been in operation for almost ...
Cached Medicine Technology:Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org 2Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org 3Merial invests US $70 million in Nanchang, China 2Merial invests US $70 million in Nanchang, China 3
(Date:9/3/2015)... ... September 03, 2015 , ... While bariatric surgeon Michael Feiz, M.D., ... when preparing for a bariatric procedure, some patients have been recently asking further questions ... instructions typical for many types of surgery that should be followed in the days ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce a ... norm not the exception. , St. Jude was recently named one of the nation’s ... making it one of only 10 hospitals in the state to earn the distinction. ...
(Date:9/3/2015)... ... , ... TransPack Toon gives users a set of 90 cartoon transitions for ... in 30 different styles. Presets range from snow, underwater, forest, futuristic, city and many ... features 90 cartoon transitions from 30 unique styles. Editors can choose between line ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Inc. , a privately held medical technology company that will bring low-cost cancer ... markets worldwide. , Preora’s proprietary and automated technology platform detects and measures ...
(Date:9/3/2015)... Buffalo, New York (PRWEB) , ... September 03, 2015 , ... ... We Do”. William Mattar, Esq. believes this does not stop at any certain ... closed captioning to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , ...
Breaking Medicine News(10 mins):Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2
... A nationwide study examining the safety of Tasers ... safe, causing a low occurrence of serious injuries., This ... associated with Tasers. It is the first injury epidemiology ... assess the overall risk and severity of injuries in ...
... no significant change in the quality of care for ... Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) ... 2007 issue of CANCER, a peer-reviewed journal of the ... Friedman from the Duke Clinical Research Institute in Durham, ...
... -- Cancer patients receiving chemotherapy have not noticed a ... of the Medicare Prescription Drug, Improvement and Modernization Act ... government reimbursement to oncologists, according to a new study ... (DCRI). , Critics of the MMA often said that ...
... - Report Suggests Millions of Sports Persons are Suffering ... health reveals that men and,women who aim to keep fit, ... of all active respondents who took part in the survey ... seem to be a common occurrence for the nations top,sports ...
... recent months, a,perfect storm of new technology and research ... and genetics, writes Lee Silver, a professor,of molecular biology ... heredity is the result of an incredibly complex interplay,among ... different,genes and even the vast stretches of "junk DNA" ...
... today expressed their great disappointment in President Bushs veto ... Health Insurance Program (SCHIP). The sentiment was expressed ... by David C. Dale, MD, FACP, president of the ... the 124,000 internal medicine physicians and medical student members ...
Cached Medicine News:Health News:Nationwide independent Taser study results suggest devices are safe 2Health News:Patients perceived cancer care unaffected by lower Medicare reimbursements 2Health News:Medicare modernization act did not change chemotherapy as feared 2Health News:More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints 2Health News:More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints 3Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 2Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 3Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 4Health News:'Great disappointment' in veto of SCHIP legislation expressed by American College of Physicians 2
... Finntips have been designed to optimize ... quality of our tip products is widely ... Finntip range has been extended over the ... of standard and special tips including filter ...
... Avant Premium Low Binding, Graduated, Long Reach Pipet ... L and 10 L. Reduces DNA and protein ... variety of Ultra-Micro Pipettors up to 10 L. ... DNAse free. AVR9LS is the Sterile Racked packaged ...
... all Gilson disposable pipette tips, ... sterilized version. Each Sterilized TowerPack ... device-quality plastic to help protect ... guaranteed by the red sticker, ...
... that demand the utmost in ... BioCon tips are endotoxin-free, DNA-free, ... BioCon tips are guaranteed to ... with biological compounds. A certificate ...
Medicine Products: